ACI
TEVA icon

AMP Capital Investors’s Teva Pharmaceuticals TEVA Stock Holding History

AMP Capital Investors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-194,283
Closed -$1.89M – 897
2021
Q3 		$1.89M Sell
194,283
-23,130
-11% -$217K 0.01% 742
2021
Q2 		$2.16M Sell
217,413
-1,114
-0.5% -$11.8K 0.01% 747
2021
Q1 		$2.52M Sell
218,527
-1,748
-0.8% -$20K 0.01% 735
2020
Q4 		$2.11M Buy
220,275
+6,344
+3% +$60.8K 0.01% 744
2020
Q3 		$1.89M Buy
213,931
+5,495
+3% +$58.1K 0.01% 727
2020
Q2 		$2.54M Buy
208,436
+42,512
+26% +$481K 0.02% 661
2020
Q1 		$1.41M Sell
165,924
-21,796
-12% -$223K 0.01% 714
2019
Q4 		$1.82M Hold
187,720
– – 0.01% 777
2019
Q3 		$1.3M Sell
187,720
-51,642
-22% -$396K 0.01% 827
2019
Q2 		$2.17M Sell
239,362
-76,626
-24% -$924K 0.01% 741
2019
Q1 		$4.92M Sell
315,988
-62,504
-17% -$1.1M 0.03% 541
2018
Q4 		$5.94M Buy
378,492
+158,862
+72% +$3.26M 0.04% 460
2018
Q3 		$4.67M Buy
219,630
+14,468
+7% +$336K 0.03% 565
2018
Q2 		$4.99M Sell
205,162
-15,000
-7% -$306K 0.03% 539
2018
Q1 		$3.75M Sell
220,162
-117,220
-35% -$2.29M 0.02% 609
2017
Q4 		$6.39M Sell
337,382
-3,492
-1% -$52.5K 0.03% 484
2017
Q3 		$6M Buy
340,874
+48,881
+17% +$1.1M 0.03% 482
2017
Q2 		$9.59M Sell
291,993
-145,271
-33% -$4.5M 0.06% 357
2017
Q1 		$14.3M Sell
437,264
-2,545
-0.6% -$86.9K 0.09% 268
2016
Q4 		$15.9M Buy
439,809
+139,736
+47% +$5.58M 0.1% 238
2016
Q3 		$13.9M Buy
300,073
+582
+0.2% +$30.4K 0.09% 253
2016
Q2 		$15.1M Buy
299,491
+30,084
+11% +$1.6M 0.1% 224
2016
Q1 		$14.7M Buy
269,407
+45,374
+20% +$2.66M 0.1% 222
2015
Q4 		$14.8M Buy
224,033
+124,698
+126% +$7.71M 0.1% 218
2015
Q3 		$5.47M Sell
99,335
-27,336
-22% -$1.77M 0.04% 441
2015
Q2 		$7.52M Sell
126,671
-55,191
-30% -$3.4M 0.05% 388
2015
Q1 		$11.4M Sell
181,862
-135,107
-43% -$7.86M 0.07% 303
2014
Q4 		$18.1M Buy
316,969
+93,326
+42% +$5.2M 0.11% 225
2014
Q3 		$12M Sell
223,643
-85
-0% -$4.5K 0.08% 300
2014
Q2 		$11.8M Sell
223,728
-34,800
-13% -$1.78M 0.07% 311
2014
Q1 		$12.8M Sell
258,528
-31,273
-11% -$1.45M 0.09% 276
2013
Q4 		$11.6M Buy
289,801
+54,666
+23% +$2.15M 0.08% 304
2013
Q3 		$8.94M Buy
235,135
+19,417
+9% +$757K 0.07% 331
2013
Q2 		$8.37M Buy
+215,718
New +$8.4M 0.06% 328

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AMP Capital Investors's TEVA Position: Q4 2021 in Review

AMP Capital Investors sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 194,283 shares — an estimated $1.89M sold.

AMP Capital Investors first reported a position in TEVA in Q2 2013 and held it in 34 quarters. The position peaked at $18.1M in Q4 2014. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • AMP Capital Investors reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 194,283 Teva Pharmaceuticals shares in Q4 2021, an estimated $1.89M.
  • AMP Capital Investors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 34 quarters.
  • AMP Capital Investors's Teva Pharmaceuticals position peaked at $18.1M in Q4 2014.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.